TransMedics Group, Inc.
TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditā¦ read more
Healthcare
Medical Devices
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$86.40
Price-2.12%
-$1.87
1Y
Price
Market Cap
$2.986b
Mid
Price/Earnings 3y Avg5y Avg
43.9x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+14.0%
EBITDA Margin+7.7%
Net Profit Margin+5.4%
Free Cash Flow Margin+14.0%
EBITDA Margin+7.7%
Net Profit Margin+5.4%
Free Cash Flow MarginRevenue
$668.468m
+10.4%
1y CAGR+43.4%
3y CAGR+72.2%
5y CAGREarnings
$151.699m
-20.3%
1y CAGR+219.3%
3y CAGR+172.2%
5y CAGREPS
$3.86
-20.7%
1y CAGR+197.5%
3y CAGR+157.5%
5y CAGRBook Value
$518.053m
$1.464b
Assets$946.343m
Liabilities$867.720m
DebtDebt to Assets
59.3%
7.2x
Debt to EBITDAFree Cash Flow
$79.041m
-40.8%
1y CAGR+94.0%
3y CAGR+12.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company